• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VEXAS 综合征的诊断和治疗方法:临床怀疑的重要性和甲氨蝶呤的应用。

Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.

机构信息

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.

Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano, Italy.

出版信息

Ann Hematol. 2024 Nov;103(11):4789-4791. doi: 10.1007/s00277-024-05863-0. Epub 2024 Aug 23.

DOI:10.1007/s00277-024-05863-0
PMID:39177793
Abstract

Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome is caused by mutations in the UBA1 gene in myeloid precursors, leading to systemic inflammatory manifestations. We present the case of a 75-year-old man presenting with fever, panniculitis, and macrocytic anemia testing repeatedly negative for UBA1 mutations in peripheral blood samples, but ultimately found positive on bone marrow mononuclear cell DNA. The man has been successfully treated with prednisone and methotrexate.

摘要

空泡性表皮松解症样包涵体肌病(VEXAS)综合征是由髓系前体细胞中 UBA1 基因突变引起的,导致全身炎症表现。我们报告了一例 75 岁男性病例,该患者表现为发热、脂膜炎和巨红细胞性贫血,在外周血样本中反复检测 UBA1 突变均为阴性,但最终在骨髓单核细胞 DNA 中检测为阳性。该患者经泼尼松和甲氨蝶呤治疗后病情得到缓解。

相似文献

1
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.VEXAS 综合征的诊断和治疗方法:临床怀疑的重要性和甲氨蝶呤的应用。
Ann Hematol. 2024 Nov;103(11):4789-4791. doi: 10.1007/s00277-024-05863-0. Epub 2024 Aug 23.
2
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a patient with subacute cutaneous lupus (SCLE).一名亚急性皮肤型红斑狼疮(SCLE)患者的空泡、E1酶、X连锁、自身炎症性、体细胞(VEXAS)综合征
BMJ Case Rep. 2025 Jan 4;18(1):e261174. doi: 10.1136/bcr-2024-261174.
3
VEXAS syndrome: An update.VEXAS 综合征:最新进展。
Joint Bone Spine. 2024 Jul;91(4):105700. doi: 10.1016/j.jbspin.2024.105700. Epub 2024 Feb 1.
4
Recurrent orbital inflammation associated with VEXAS syndrome.与 VEXAS 综合征相关的复发性眼眶炎症。
Orbit. 2024 Jun;43(3):350-353. doi: 10.1080/01676830.2022.2126501. Epub 2022 Sep 27.
5
UBA1 and DNMT3A mutations in VEXAS syndrome. A case report and literature review.VEXAS综合征中的UBA1和DNMT3A突变:一例报告及文献综述
Mod Rheumatol Case Rep. 2022 Jan 7;6(1):134-139. doi: 10.1093/mrcr/rxab021.
6
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.VEXAS综合征中纵向UBA1追踪的方法学及临床应用价值
Br J Haematol. 2025 Jan;206(1):331-336. doi: 10.1111/bjh.19897. Epub 2024 Nov 13.
7
The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern.X 连锁空泡化相关、E1 酶缺陷、自体炎症、体细胞综合征肺部受累的异质性:类过敏性肺炎表现 1 例。
Reumatismo. 2024 Jun 24;76(2). doi: 10.4081/reumatismo.2024.1611.
8
Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.病例报告:遗传性双重打击:长期难治性自身炎症性疾病患者的 VEXAS 和 TET2 阳性骨髓增生异常综合征。
Front Immunol. 2022 Jan 20;12:800149. doi: 10.3389/fimmu.2021.800149. eCollection 2021.
9
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.空泡、E1 酶、X 连锁、自身炎症、体细胞(VEXAS)综合征的临床特征、疾病轨迹和治疗:系统评价。
Rheumatol Int. 2024 Jul;44(7):1219-1232. doi: 10.1007/s00296-023-05513-0. Epub 2023 Dec 21.
10
The Challenging and Unique Diagnosis of VEXAS Syndrome: A Case Report.VEXAS综合征的具有挑战性的独特诊断:一例报告
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251325416. doi: 10.1177/23247096251325416. Epub 2025 Apr 4.

本文引用的文献

1
Therapy-related MDS dissected based on primary disease and treatment-a nationwide perspective.基于原发疾病和治疗的治疗相关性 MDS 解析:一项全国性视角。
Leukemia. 2023 May;37(5):1103-1112. doi: 10.1038/s41375-023-01864-6. Epub 2023 Mar 17.
2
An update on VEXAS syndrome.VEXAS综合征的最新情况。
Expert Rev Clin Immunol. 2023 Feb;19(2):203-215. doi: 10.1080/1744666X.2023.2157262. Epub 2022 Dec 26.
3
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones.配对的骨髓和外周血样本表明,一些 CH 克隆并未广泛传播。
Blood Adv. 2023 May 9;7(9):1910-1914. doi: 10.1182/bloodadvances.2022008521.
4
Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections.在重症监护环境中,托珠单抗治疗 COVID-19 高炎症患者与医院获得性细菌和侵袭性真菌感染发生率升高之间的关联。
J Hosp Infect. 2022 Aug;126:29-36. doi: 10.1016/j.jhin.2022.04.007. Epub 2022 Apr 23.
5
Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms.血液系统肿瘤中外周血与骨髓下一代测序的一致性
Adv Hematol. 2022 Mar 26;2022:8091746. doi: 10.1155/2022/8091746. eCollection 2022.
6
Treatment of relapsing polychondritis: a systematic review.复发性多软骨炎的治疗:系统评价。
Clin Exp Rheumatol. 2022 May;40 Suppl 134(5):81-85. doi: 10.55563/clinexprheumatol/h9gq1o. Epub 2022 Jan 28.
7
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.托法替尼治疗类风湿关节炎与心血管和癌症风险。
N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927.
8
Towards treatments for VEXAS.迈向VEXAS综合征的治疗方法。
Br J Haematol. 2022 Feb;196(4):804-805. doi: 10.1111/bjh.17930. Epub 2021 Nov 3.
9
Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS.UBA1 体细胞突变导致的成人发作性自身炎症:荷兰 VEXAS 患者的病例系列。
J Allergy Clin Immunol. 2022 Jan;149(1):432-439.e4. doi: 10.1016/j.jaci.2021.05.014. Epub 2021 May 25.
10
Somatic Mutations in and Severe Adult-Onset Autoinflammatory Disease.和严重成人发病的自身炎症性疾病中的体细胞突变。
N Engl J Med. 2020 Dec 31;383(27):2628-2638. doi: 10.1056/NEJMoa2026834. Epub 2020 Oct 27.